Skip to content

High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia

Study on High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia After Kasai Portoenterostomy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05072626
Enrollment
300
Registered
2021-10-11
Start date
2021-10-11
Completion date
2028-12-31
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Atresia, Infant, Medium-chain Triglyceride, Nutrition Support

Keywords

Biliary Atresia, Kasai portoenterostomy, Nutrition Support, medium-chain triglyceride

Brief summary

This study is a prospective, single center and observational open clinical study.

Detailed description

Biliary atresia (BA) is a significant disease leading to liver failure in infancy, with BA accounting for 50% of infant liver transplantation cases. Many BA children experience complications related to malnutrition, particularly during the first year of life. These complications are primarily characterized by reduced muscle mass and structural protein, impaired bone mineralization, diminished fat reserves, and deficiencies in vitamins and trace elements. Some studies have indicated that oral administration of specialized medium-chain triglycerides (MCT) and branched-chain amino acids FSMP with polysaccharides still result in malnutrition and growth retardation among BA children, necessitating enteral nutrition support treatment through tube feeding. The American Association for the Study of Biliary Atresia conducted a study on the prognosis of 104 children with biliary atresia after Kasai surgery across six clinical centers. They found that the key period for changes in growth rate occurred six months post-surgery, with faster-growing children exhibiting better prognoses compared to those with slower growth rates. Active nutritional therapy can enhance the prognosis of children with biliary atresia, particularly before and after Kasai surgery within the initial six-month period following surgery. Currently, there is no standardized process for using Foods for Special Medical Purpose in China nor any regulations governing the addition and monitoring of trace elements and vitamins. Therefore, this study aims to improve overall outcomes for children with biliary atresia through standardized nutrition assessment procedures as well as education, intervention, and follow-up measures.A total of 300 hospitalized patients were enrolled, all of whom received high MCT formula nutritional support following the Kasai operation, in order to investigate the impact of high MCT formula on the nutritional status and growth of children with biliary atresia after undergoing the Kasai procedure.

Interventions

None listed

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 3 Months
Healthy volunteers
No

Inclusion criteria

The Kasai procedure for infants with biliary atresia under the age of 3 months.

Exclusion criteria

* Complicated with cirrhosis, hepatitis, or other hepatic disorders; * Complicated with other systemic serious diseases (such as congenital multiple malformations, chromosome abnormalities)

Design outcomes

Primary

MeasureTime frameDescription
Z-scores of body weight3 months after Kasai portoenterostomyThe patient will be weighed in the recumbent position on an electronic infant scale. Z-scores for weight for age (WAZ) were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.

Secondary

MeasureTime frameDescription
Z-scores of body length1 month after Kasai portoenterostomyZ-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Z-scores of body weight1 month after Kasai portoenterostomyZ-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Z-scores of head circumference1 month after Kasai portoenterostomyZ-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
level of vitamin A1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
level of 25(OH) D1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
level of 25(OH) D6 months after Kasai portoenterostomyBlood biochemical data are from clinical database.
level of vitamin E1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
level of vitamin K1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
Aspartate aminotransferase1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
Alanine aminotransferase1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
Total Bilirubin1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
Direct Bilirubin1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
Gamma-glutamyl transferase1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
Total bile acid1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
White blood cell1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
lymphocyte1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
Neutrophil count1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
International Normalized Ratio1 month after Kasai portoenterostomyBlood biochemical data are from clinical database.
Incidence of postoperative cholangitis1 year after Kasai portoenterostomyData from clinical database
Liver transplantation1 year after Kasai portoenterostomyData from clinical database
MMP-71 months after Kasai portoenterostomyData from clinical database
Intestinal flora1 months after Kasai portoenterostomyData from clinical database
bile acid spectrum1 months after Kasai portoenterostomyData from clinical database

Countries

China

Contacts

CONTACTTian Qian, M.D. PhD
drqiantian@fudan.edu.cn+8602164931981
CONTACTXiaoyan Gong, Bachelor
xygongfudan@163.com+8602164931980
STUDY_DIRECTORTian Qian, M.D. PhD

Children's Hospital of Fudan University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026